Athersys (NASDAQ:ATHX) +200% after inking a deal with Pfizer (NYSE:PFE) to develop and market its experimental stem cell therapy MultiStem. Pfizer will pay $6M up front, fund the drug's R&D, and pay up to $105M on milestones.
Athersys (NASDAQ:ATHX) +200% after inking a deal with Pfizer (NYSE:PFE) to develop and market...
Recommended For You
More Trending News
About ATHXQ Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| ATHXQ | - | - |
| Athersys, Inc. | ||